Effects of vedolizumab in Japanese patients with Crohn’s disease: a prospective, multicenter, randomized, placebo-controlled Phase 3 trial with exploratory analyses
Watanabe, Kenji, Motoya, Satoshi, Ogata, Haruhiko, Kanai, Takanori, Matsui, Toshiyuki, Suzuki, Yasuo, Shikamura, Mitsuhiro, Sugiura, Kenkichi, Oda, Kazunori, Hori, Tetsuharu, Araki, Takahiro, Watanabe, Mamoru, Hibi, Toshifumi
Published in Journal of gastroenterology (01.03.2020)
Published in Journal of gastroenterology (01.03.2020)
Get full text
Journal Article
Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study
Motoya, Satoshi, Watanabe, Kenji, Ogata, Haruhiko, Kanai, Takanori, Matsui, Toshiyuki, Suzuki, Yasuo, Shikamura, Mitsuhiro, Sugiura, Kenkichi, Oda, Kazunori, Hori, Tetsuharu, Araki, Takahiro, Watanabe, Mamoru, Hibi, Toshifumi
Published in PloS one (26.02.2019)
Published in PloS one (26.02.2019)
Get full text
Journal Article
Correction: Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study
Motoya, Satoshi, Watanabe, Kenji, Ogata, Haruhiko, Kanai, Takanori, Matsui, Toshiyuki, Suzuki, Yasuo, Shikamura, Mitsuhiro, Sugiura, Kenkichi, Oda, Kazunori, Hori, Tetsuharu, Araki, Takahiro, Watanabe, Mamoru, Hibi, Toshifumi
Published in PloS one (11.04.2019)
Published in PloS one (11.04.2019)
Get full text
Journal Article
Efficacy and safety of a new vedolizumab subcutaneous formulation in Japanese patients with moderately to severely active ulcerative colitis
Kobayashi, Taku, Ito, Hiroaki, Ashida, Toshifumi, Yokoyama, Tadashi, Nagahori, Masakazu, Inaba, Tomoki, Shikamura, Mitsuhiro, Yamaguchi, Takayoshi, Hori, Tetsuharu, Pinton, Philippe, Watanabe, Mamoru, Hibi, Toshifumi
Published in Intestinal research (01.10.2021)
Published in Intestinal research (01.10.2021)
Get full text
Journal Article
Efficacy and safety of a new vedolizumab subcutaneous formulation in Japanese patients with moderately to severely active ulcerative colitis
Taku Kobayashi, Hiroaki Ito, Toshifumi Ashida, Tadashi Yokoyama, Masakazu Nagahori, Tomoki Inaba, Mitsuhiro Shikamura, Takayoshi Yamaguchi, Tetsuharu Hori, Philippe Pinton, Mamoru Watanabe, Toshifumi Hibi
Published in Intestinal research (Intest Res) (30.10.2021)
Get full text
Published in Intestinal research (Intest Res) (30.10.2021)
Journal Article
Comparative effectiveness of sodium‐glucose cotransporter‐2 inhibitors and dipeptidyl peptidase‐4 inhibitors in improvement of fatty liver index in patients with type 2 diabetes mellitus and metabolic dysfunction‐associated steatotic liver disease: A retrospective nationwide claims database study in Japan
Shikamura, Mitsuhiro, Takayama, Atsushi, Takeuchi, Masato, Kawakami, Koji
Published in Diabetes, obesity & metabolism (01.08.2024)
Published in Diabetes, obesity & metabolism (01.08.2024)
Get full text
Journal Article
Potential benefits of immunomodulator use with vedolizumab for maintenance of remission in ulcerative colitis
Naganuma, Makoto, Watanabe, Kenji, Motoya, Satoshi, Ogata, Haruhiko, Matsui, Toshiyuki, Suzuki, Yasuo, Ursos, Lyann, Sakamoto, Shigeru, Shikamura, Mitsuhiro, Hori, Tetsuharu, Fernandez, Jovelle, Watanabe, Mamoru, Hibi, Toshifumi, Kanai, Takanori
Published in Journal of gastroenterology and hepatology (01.01.2022)
Published in Journal of gastroenterology and hepatology (01.01.2022)
Get full text
Journal Article
Week 2 Symptomatic Response with Vedolizumab as a Predictive Factor in Japanese Anti-TNFα-Naive Patients with Ulcerative Colitis: A post hoc Analysis of a Randomized, Placebo-Controlled Phase 3 Trial
Nagahori, Masakazu, Watanabe, Kenji, Motoya, Satoshi, Ogata, Haruhiko, Kanai, Takanori, Matsui, Toshiyuki, Suzuki, Yasuo, Pinton, Philippe, Ursos, Lyann, Sakamoto, Shigeru, Shikamura, Mitsuhiro, Hori, Tetsuharu, Fernandez, Jovelle, Hibi, Toshifumi, Watanabe, Mamoru
Published in Digestion (01.09.2021)
Published in Digestion (01.09.2021)
Get full text
Journal Article
Tu1746 – A Phase 3 Study of Vedolizumab for Induction and Maintenance Therapy in Japanese Patients with Moderate to Severe Crohn's Disease
Ogata, Haruhiko, Motoya, Satoshi, Watanabe, Kenji, Kanai, Takanori, Matsui, Toshiyuki, Suzuki, Yasuo, Shikamura, Mitsuhiro, Sugiura, Kenkichi, Oda, Kazunori, Hori, Tetsuharu, Araki, Takahiro, Watanabe, Mamoru, Hibi, Toshifumi
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2019)
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2019)
Get full text
Journal Article
Sa1751 - A Phase 3 Study of Vedolizumab for Induction and Maintenance Therapy in Japanese Patients with Moderately to Severely Active Ulcerative Colitis
Watanabe, Mamoru, Motoya, Satoshi, Watanabe, Kenji, Ogata, Haruhiko, Kanai, Takanori, Matsui, Toshiyuki, Suzuki, Yasuo, Shikamura, Mitsuhiro, Igeta, Masataka, Oda, Kazunori, Hori, Tetsuharu, Araki, Takahiro, Hibi, Toshifumi
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2018)
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2018)
Get full text
Journal Article